Sabeha Biichlé

1.5k total citations
28 papers, 660 citations indexed

About

Sabeha Biichlé is a scholar working on Immunology, Oncology and Dermatology. According to data from OpenAlex, Sabeha Biichlé has authored 28 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Oncology and 9 papers in Dermatology. Recurrent topics in Sabeha Biichlé's work include CAR-T cell therapy research (10 papers), Cutaneous lymphoproliferative disorders research (9 papers) and Extracellular vesicles in disease (4 papers). Sabeha Biichlé is often cited by papers focused on CAR-T cell therapy research (10 papers), Cutaneous lymphoproliferative disorders research (9 papers) and Extracellular vesicles in disease (4 papers). Sabeha Biichlé collaborates with scholars based in France, United States and Lebanon. Sabeha Biichlé's co-authors include Philippe Saas, Estelle Seillès, Francine Garnache‐Ottou, Christophe Ferrand, Pierre Tiberghien, Éric Deconinck, Sylvain Perruche, Laurence Chaperot, Manoel de Carvalho and Emeline Masson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Sabeha Biichlé

25 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sabeha Biichlé France 13 276 231 195 167 122 28 660
Silvana Festa Italy 7 292 1.1× 231 1.0× 84 0.4× 104 0.6× 120 1.0× 7 616
Vinodh Pillai United States 14 372 1.3× 229 1.0× 173 0.9× 43 0.3× 65 0.5× 46 808
Armin G. Jegalian United States 11 287 1.0× 347 1.5× 138 0.7× 197 1.2× 172 1.4× 14 862
M. C. Jendro Germany 13 352 1.3× 174 0.8× 114 0.6× 35 0.2× 81 0.7× 22 867
Piotr Kuśnierczyk Poland 22 1.1k 3.9× 127 0.5× 158 0.8× 92 0.6× 63 0.5× 93 1.4k
Kenji Katamura Japan 15 417 1.5× 124 0.5× 198 1.0× 72 0.4× 227 1.9× 38 1.1k
Mayra Senices United States 5 1.1k 4.1× 329 1.4× 97 0.5× 205 1.2× 71 0.6× 6 1.3k
Efrem Eren United Kingdom 12 613 2.2× 73 0.3× 102 0.5× 76 0.5× 110 0.9× 26 908
Jacqueline Rivet France 15 144 0.5× 193 0.8× 87 0.4× 305 1.8× 244 2.0× 49 674
Edgardo Reyes Mexico 17 154 0.6× 326 1.4× 144 0.7× 42 0.3× 160 1.3× 40 846

Countries citing papers authored by Sabeha Biichlé

Since Specialization
Citations

This map shows the geographic impact of Sabeha Biichlé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabeha Biichlé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabeha Biichlé more than expected).

Fields of papers citing papers by Sabeha Biichlé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabeha Biichlé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabeha Biichlé. The network helps show where Sabeha Biichlé may publish in the future.

Co-authorship network of co-authors of Sabeha Biichlé

This figure shows the co-authorship network connecting the top 25 collaborators of Sabeha Biichlé. A scholar is included among the top collaborators of Sabeha Biichlé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabeha Biichlé. Sabeha Biichlé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roussel, Xavier, Sabeha Biichlé, Maxime Fredon, et al.. (2025). New leads to enhance tagraxofusp efficacy in pDC-AML. PubMed. 2(2). 100066–100066.
2.
Fredon, Maxime, Sabeha Biichlé, Florian Renosi, et al.. (2025). Venetoclax in the Therapeutic Strategy for BPDCN Management. eJHaem. 6(4). e70070–e70070.
3.
Roussel, Xavier, Sabeha Biichlé, Maxime Fredon, et al.. (2023). Analysis of Tagraxofusp Activity in AML-Pdc As a Single Agent and in Combination with BCL2 Inhibitors. Blood. 142(Supplement 1). 2783–2783. 1 indexed citations
4.
Galaine, Jeanne, Maxime Fredon, Sabeha Biichlé, et al.. (2022). Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells. Cancers. 14(13). 3168–3168. 22 indexed citations
5.
Warda, Walid, Fabrice Larosa, Éric Deconinck, et al.. (2018). CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor–Engineered T Cells. Cancer Research. 79(3). 663–675. 68 indexed citations
6.
Philippe, Laure, Sabeha Biichlé, Sophie Perrin, et al.. (2017). Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm. Haematologica. 102(11). 1861–1868. 36 indexed citations
7.
Saas, Philippe, Sabeha Biichlé, Marc Puyraveau, et al.. (2016). Vitreous Microparticle Shedding in Retinal Detachment: A Prospective Comparative Study. Investigative Ophthalmology & Visual Science. 57(1). 40–40. 13 indexed citations
8.
Masson, David, Anne Roggy, Christophe Roumier, et al.. (2016). LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis. Blood. 128(23). 2694–2707. 47 indexed citations
9.
Pelletier, F., Francine Garnache‐Ottou, Sabeha Biichlé, et al.. (2013). Increased Levels of Circulating Microparticles Are Associated with Increased Procoagulant Activity in Patients with Cutaneous Malignant Melanoma. Journal of Investigative Dermatology. 134(1). 176–182. 39 indexed citations
10.
Pelletier, F., Francine Garnache‐Ottou, Sabeha Biichlé, et al.. (2013). Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanoma. Annales de Dermatologie et de Vénéréologie. 140(12). S651–S651. 1 indexed citations
11.
Angelot‐Delettre, Fanny, Sabeha Biichlé, Christophe Ferrand, et al.. (2012). Intracytoplasmic detection of TCL1—but not ILT7—by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis. Cytometry Part A. 81A(8). 718–724. 15 indexed citations
12.
Seillès, Estelle, Sabeha Biichlé, Yael Berda, et al.. (2009). Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica. 94(11). 1502–1512. 75 indexed citations
13.
Garnache‐Ottou, Francine, Jean Feuillard, Christophe Ferrand, et al.. (2009). Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. British Journal of Haematology. 145(5). 624–636. 118 indexed citations
14.
Kleinclauss, F., Sylvain Perruche, Emeline Masson, et al.. (2005). Intravenous apoptotic spleen cell infusion induces a TGF-β-dependent regulatory T-cell expansion. Cell Death and Differentiation. 13(1). 41–52. 129 indexed citations
16.
18.
Riethmuller, D., Sabeha Biichlé, D. Meillet, et al.. (2002). VALIDATION OF A HIGH SENSITIVE IMMUNOENZYMATIC ASSAY TO ESTABLISH THE ORIGIN OF IMMUNOGLOBULINS IN FEMALE GENITAL SECRETIONS. Journal of Immunoassay and Immunochemistry. 23(2). 145–162. 16 indexed citations
19.
Biichlé, Sabeha, et al.. (2002). Nonspecific Secretory Immunity in HIV-Infected Patients With Oral Candidiasis. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(3). 276–284. 13 indexed citations
20.
Rossel, Mireille, Élisabeth Brambilla, Marc Billaud, et al.. (1993). Nonspecific Increased Serum Levels of Secretory Component in Lung Tumors: Relationship to the Gene Expression of the Transmembrane Receptor Form. American Journal of Respiratory Cell and Molecular Biology. 9(3). 341–346. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026